Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Both the innate and adaptive immune systems contribute to the development of NAFLD. Pathogen-associated molecular patterns and danger-associated molecular patterns are known to activate a variety of pattern-recognition receptors that result in inflammation. The key features of the immune system and inflammatory pathways in the development of NAFLD are discussed in this review
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic l...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways respon...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndr...
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and on...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic fatty liver disease (NAFLD) is considered to be one of the most frequent chronic liver...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Liver disease and its complications affect millions of people worldwide. NAFLD (non-alcoholic fatty ...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic l...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways respon...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease worldwide, both...
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndr...
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and on...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring steatosis and ...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic fatty liver disease (NAFLD) is considered to be one of the most frequent chronic liver...
International audienceThe incidence of non-alcoholic fatty liver disease (NAFLD) has increased signi...
Liver disease and its complications affect millions of people worldwide. NAFLD (non-alcoholic fatty ...
The low grade inflammatory state present in obesity promotes the progression of Non-Alcoholic Fatty ...
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic l...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways respon...